A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD4360 in Adult Participants with Advanced Solid Tumors
A Phase 2, parallel group study to investigate the efficacy and safety of PS101-mediated Acoustic Cluster Therapy with modified FOLFIRINOX or nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer.
A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Tumours Expressing Claudin 18.2
A Phase 1 Open-Label Study of PF-07934040 as a Single-Agent and in Combination With Other Targeted Agents in Participants with Advanced Solid Tumors Harboring Mutations in the KRAS Gene.
A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran plus Atezolizumab and mFolfirinox versus mFolfirinox Alone in Patients with Respected Pancreatic Ductal Adenocarcinoma
A Randomized Phase II Trial of Nab-paclitaxel + Gemcitabine with or without Botensilimab for Metastatic Pancreatic Cancer Who Have Progressed on FOLFIRINOX
